Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Cantor Fitzgerald
McKinsey
Cerilliant
Citi
Daiichi Sankyo
Teva
Argus Health
Boehringer Ingelheim
Chubb

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,705,789

« Back to Dashboard

Summary for Patent: 4,705,789
Title: Solutions of lactic acid salts of piperazinylquinolone- and piperazinyl-azaquinolone-carboxylic acids
Abstract:The invention relates to solutions of piperazinyl-quinolone- and piperazinyl-azaquinolone-carboxylic acids, and in particular both ready-to-use injection and/or infusion solutions and dosage forms which can be converted into such injection and/or infusion solutions before use. The solutions according to the invention are characterized in that, besides the lactic acid salts of the active substance and, if appropriate, customary auxiliaries, they additionally contain at least one acid which does not lead to precipitates, in particular lactic acid.
Inventor(s): Grohe; Klaus (Odenthal, DE), Lammens; Robert (Leverkusen, DE)
Assignee: Bayer Aktiengesellschaft (Leverkusen, DE)
Application Number:06/644,834
Patent Claim Types:
see list of patent claims
Formulation; Compound; Composition;

Drugs Protected by US Patent 4,705,789

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,705,789

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany3333719Sep 17, 1983

International Patents Family Members for US Patent 4,705,789

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 38332 ➤ Try a Free Trial
Australia 3297684 ➤ Try a Free Trial
Australia 562507 ➤ Try a Free Trial
Canada 1228547 ➤ Try a Free Trial
German Democratic Republic 227882 ➤ Try a Free Trial
Germany 3333719 ➤ Try a Free Trial
Germany 3474915 ➤ Try a Free Trial
Denmark 162811 ➤ Try a Free Trial
Denmark 441084 ➤ Try a Free Trial
European Patent Office 0138018 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Johnson and Johnson
Citi
Covington
Federal Trade Commission
QuintilesIMS
Teva
Deloitte
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot